Literature DB >> 17680225

DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.

Hans Strasser1, Gerhard G Grabenbauer, Carl N Sprung, Rolf Sauer, Luitpold V R Distel.   

Abstract

BACKGROUND AND
PURPOSE: DNA double-strand breaks (dsbs) in lymphoblastoid cell lines (LCLs), fibroblasts and white blood cells from healthy donors, cancer patients with and without late effects of grade 3-4 (RTOG) as well as donors with known radiosensitivity syndromes were examined with the aim to detect dsb repair ability as a marker for radiosensitivity.
MATERIAL AND METHODS: LCLs from six healthy donors, seven patients with a heterozygous or homozygous genotype for ataxia-telangiectasia (ATM) and Nijmegen breakage syndrome (NBS), two patients with a late toxicity of grade 3-4 (RTOG), and one cell line with a ligase IV-/- status and its parental cell line were examined. Furthermore, fibroblasts from patients with ATM, NBS, two healthy control individuals, and leukocytes from 16 healthy and 22 cancer patients including seven patients with clinical hypersensitivity grade 3 (RTOG) were examined. Cells were irradiated in vitro with 0-150 Gy. Initial damage as well as remaining damage after 8 and 24 h were measured using constant field gel electrophoresis.
RESULTS: In contrast to cells derived from patients homozygous for NBS, impaired dsb repair ability could be detected both in fibroblast and lymphoblastoid cells from ATM and ligase IV-/- patients. The dsb repair ability of all 38 leukocyte cell lines (patients with grade 3-4 late effects and controls) was similar, whereas the initial damage among healthy donors was less.
CONCLUSION: Despite showing a clinically elevated radiosensitivity after irradiation, the DNA repair of the patients with clinical hypersensitivity grade 3 (RTOG) appeared to be normal. Other mechanisms such as mutations, altered cell cycle or defective apoptosis could play a critical role toward determining radiosensitivity.

Entities:  

Mesh:

Year:  2007        PMID: 17680225     DOI: 10.1007/s00066-007-1683-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

Review 1.  [Prediction of the reaction of normal tissue and tumor cells to radiotherapy].

Authors:  E Dikomey; J Dahm-Daphi; L Distel
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

2.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

3.  Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation.

Authors:  Nils H Nicolay; Eva Sommer; Ramon Lopez Perez; Ute Wirkner; Tilman Bostel; Anthony D Ho; Michael Lahn; Jürgen Debus; Rainer Saffrich; Peter E Huber
Journal:  Strahlenther Onkol       Date:  2014-05-27       Impact factor: 3.621

4.  Does single-dose cell resistance to the radio-mimetic zeocin correlate with a zeocin-induced adaptive response in Chlamydomonas reinhardtii strains?

Authors:  E Dimova; M Dimitrova; D Miteva; Z Mitrovska; N P Yurina; P E Bryant; S Chankova
Journal:  Radiat Environ Biophys       Date:  2008-10-28       Impact factor: 1.925

Review 5.  Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.

Authors:  Klaus Dittmann; Claus Mayer; H Peter Rodemann
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

6.  High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.

Authors:  Hendrik Andreas Wolff; Jochen Gaedcke; Klaus Jung; Robert Michael Hermann; Hilka Rothe; Markus Schirmer; Torsten Liersch; Markus Karl Alfred Herrmann; Steffen Hennies; Margret Rave-Fränk; Clemens Friedrich Hess; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

7.  Localized morphea--a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea.

Authors:  Thomas Herrmann; Claudia Günther; Peter Csere
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

Review 8.  Lethal outcome after pelvic salvage radiotherapy in a patient with prostate cancer due to increased radiosensitivity : Case report and literature review.

Authors:  Antje Fahrig; T Koch; M Lenhart; P Rieckmann; R Fietkau; Luitpold Distel; B Schuster
Journal:  Strahlenther Onkol       Date:  2017-09-08       Impact factor: 3.621

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.